Healthcare Global Enterprises cash flow

Latest FY26

Cash from operations: ₹347cr+9.5% on FY25
Capital spending: ₹292cr+39.8% on FY25
Free cash flow: ₹55.0cr−49.2% on FY25
Cash from financing: ₹241cr−₹42.4 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	244	211	174	163
	—	31.9	0.0	0.0	0.0
	—	177	155	109	104
	—	−14.3	−15.9	−12.7	−11.8
	—	−0.1	−0.2	−0.2	−0.0
	—	−56.6	6.5	7.9	6.5
	—	−0.2	−0.1	−0.5	−0.3
	—	13.1	1.5	−8.7	29.4
	—	−9.4	−9.6	−4.0	−8.3
	—	−42.5	−80.1	−5.3	−94.0
	—	−1.3	−10.2	−7.9	−17.3
	—	2.1	29.5	10.0	56.4
	—	8.5	4.5	2.6	2.0
Cash from operating activities
	38.3	25.5	56.2	67.3	44.9
	—	353	293	265	229
	—	379	349	332	274
	—	31.8	31.9	47.4	22.7
	—	347	317	285	252
Cash from investing activities
	—	292	209	186	133
	—	3.6	1.5	1.7	7.6
	—	0.0	197	48.5	0.0
	—	11.9	9.5	8.2	6.6
	—	99.1	−92.7	−1.4	−13.9
	—	−177	−488	−226	−133
Cash from financing activities
	—	444	1.6	2.0	0.9
	—	0.0	0.0	42.2	0.0
	—	129	222	290	55.4
	—	119	77.6	151	62.8
	—	131	108	0.0	0.0
	—	—	—	96.2	85.7
	—	82.7	76.2	66.5	47.9
	—	0.6	−4.2	0.0	0.0
	—	241	−42.4	−64.0	−140
	—	410	−213	−5.2	−21.5
	—	410	−213	−5.2	−21.5
	—	—	−47.1	166	171
Reference items
	480	466	387	330	299
	18.3%	18.3%	17.4%	17.2%	17.6%
	55.0	55.0	108	98.9	118
	—	−120	362	306	—
	₹3.82	₹3.82	₹7.52	₹6.87	₹8.22
	154.74×	—	—	—	—
	—	15.24×	6.49×	6.89×	14.28×
	—	31.8	31.9	47.4	22.7
	—	82.7	76.2	66.5	47.9

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

HCG₹591.45

Healthcare Global Enterprises Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP FORTIS RAINBOW JLHL CORONA MARKSANS METROPOLIS PARKHOSPSMcap ₹8,511 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	163.5	174.4	211.3	244.2	—
+ Impairment Loss / (Reversal)	0.0	0.0	0.0	31.9	—
+ Finance Costs	103.5	108.7	154.6	176.6	—
+ Interest Income	-11.8	-12.7	-15.9	-14.3	—
+ Fair Value (Gains) / Losses	-0.0	-0.2	-0.2	-0.1	—
+ Share-based Payments	6.5	7.9	6.5	-56.6	—
+ Unrealised FX (Gain) / Loss	-0.3	-0.5	-0.1	-0.2	—
+ Other Non-cash Items	29.4	-8.7	1.5	13.1	—
Changes in Working Capital
+ Inventories	-8.3	-4.0	-9.6	-9.4	—
+ Trade Receivables — Current	-94.0	-5.3	-80.1	-42.5	—
+ Other Financial Assets — Current	-17.3	-7.9	-10.2	-1.3	—
+ Trade Payables — Current	56.4	10.0	29.5	2.1	—
+ Provisions — Current	2.0	2.6	4.5	8.5	—
Cash from Operating Activities
Profit Before Tax (per I/S)	44.9	67.3	56.2	25.5	38.3
+ Total Adjustments (incl. Working Capital)	229.4	264.6	292.8	353.5	—
Cash from Operations (pre-tax)	274.3	331.9	349.0	378.9	—
+ Income Taxes Paid	22.7	47.4	31.9	31.8	—
Cash from Operating Activities	251.6	284.6	317.1	347.1	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	133.2	185.7	208.9	292.1	—
+ Disp of Fixed Assets	7.6	1.7	1.5	3.6	—
+ Acq of Subsidiaries / Businesses (net)	0.0	48.5	197.2	0.0	—
+ Interest Received — Investing	6.6	8.2	9.5	11.9	—
+ Other Inflows / (Outflows) — Investing	-13.9	-1.4	-92.7	99.1	—
Cash from Investing Activities	-133.0	-225.7	-487.8	-177.5	—
Cash from Financing Activities
+ Proceeds from Issue of Shares	0.9	2.0	1.6	444.0	—
+ Payments — Change in Ownership of Subsidiaries	0.0	42.2	0.0	0.0	—
+ Proceeds from Borrowings	55.4	290.0	222.1	128.7	—
+ Repayment of Borrowings	62.8	151.1	77.6	119.0	—
+ Payment of Lease Liabilities	0.0	0.0	108.2	130.9	—
+ Payment of Finance Lease Liabilities	85.7	96.2	—	—	—
+ Interest Paid	47.9	66.5	76.2	82.7	—
+ Other Inflows / (Outflows) — Financing	0.0	0.0	-4.2	0.6	—
Cash from Financing Activities	-140.1	-64.0	-42.4	240.7	—
Net Changes in Cash (pre-FX)	-21.5	-5.2	-213.1	410.3	—
Net Changes in Cash	-21.5	-5.2	-213.1	410.3	—
Closing Cash	171.2	166.0	-47.1	—	—
Reference Items
EBITDA	298.7	329.6	387.3	465.8	480.3
EBITDA Margin %	17.63	17.24	17.42	18.30	18.28
Free Cash Flow (CFO − Capex)	118.4	98.9	108.3	55.0	55.0
Free Cash Flow to Equity	—	305.9	361.6	-119.5	—
Free Cash Flow per Basic Share	8.22	6.87	7.52	3.82	3.82
Price to Free Cash Flow	—	—	—	—	154.74
Cash Flow to Net Income	14.28	6.89	6.49	15.24	—
Cash Paid for Taxes	22.7	47.4	31.9	31.8	—
Cash Paid for Interest	47.9	66.5	76.2	82.7	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.